Pharma Journalist -

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) + MEKTOVI (binimetinib) for the treatment of adult patients with metastatic…
Read More...

MimiVax, Inc., a biotechnology company focused on the development of glioblastoma vaccine therapy, announced that the United States Food and Drug Administration (FDA) has granted Fast…
Read More...

See full summit details here. Over the past year, the allogeneic cell therapy landscape has continued to evolve. Amidst the clinical and commercial developments, the challenging…
Read More...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, announced that global…
Read More...

Bayer has opened a new cell therapy manufacturing facility in Berkeley, California, USA, to offer cell therapies to patients worldwide. The $250 million investment will be used to…
Read More...

Swedish biotech company Salipro Biotech AB and Estonian biotechnology company Icosagen announced that they entered into a multi-target antibody research agreement to advance drug…
Read More...

BioMap announced a groundbreaking strategic collaboration with Sanofi to co-develop cutting-edge AI modules for biotherapeutic drug discovery leveraging BioMap’s AI platform. “As the…
Read More...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive license agreement with CanariaBio, a Korean biopharmaceutical company focused on the…
Read More...

Ultimovacs ASA, a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug…
Read More...

Novartis, a global leader in immuno-dermatology and rheumatology, announced that the US Food and Drug Administration (FDA) has approved an intravenous (IV) formulation of Cosentyx…
Read More...